+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug Administration



Prescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug Administration



Plos One 11(5): E0155035



The volume of prescription drug promotion over time is often measured by assessing changes in ad spending. However, this method obscures the fact that some types of advertising are more expensive than others. Another way to measure the changes in prescription drug promotion over time is to assess the number of promotional pieces submitted to the U.S. Food and Drug Administration (FDA). Form FDA 2253 collects information such as the date submitted and the type of material submitted. We analyzed data from Forms FDA 2253 received from 2001-2014. We examined the frequency of submissions by audience (consumer and healthcare professional) and type of promotional material. There was a noted increase in prescription drug promotion submissions across all media in the early 2000s. Although non-Internet promotion submissions have since plateaued, Internet promotion continued to increase. These results can help public health advocates and regulators focus attention and resources.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058610167

Download citation: RISBibTeXText

PMID: 27149513

DOI: 10.1371/journal.pone.0155035


Related references

Clinical Evidence Supporting US Food and Drug Administration Approval of Otolaryngologic Prescription Drug Indications, 2005-2014. Otolaryngology--Head and Neck Surgery 156(4): 683-692, 2017

Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures. Food and Drug Administration, HHS. Final rule. Federal Register 64(232): 67720-67763, 2000

Off-label antidepressant prescription in pediatric outpatients based on China Food and Drug Administration and Food and Drug Administration regulations: a Chinese retrospective study. International Clinical Psychopharmacology 33(3): 172-179, 2018

Key Findings from Preclinical and Clinical Drug Interaction Studies Presented in New Drug and Biological License Applications Approved by the Food and Drug Administration in 2014. Drug Metabolism and Disposition: the Biological Fate of Chemicals 44(1): 83, 2016

The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?. Food and Drug Law Journal 60(2): 261-338, 2005

Food and Drug Administration Modernization Act of 1997; list of documents issued by the Food and Drug Administration that apply to medical devices regulated by the Center for Biologics Evaluation and Research. Food and Drug Administration, HHS. Notice. Federal Register 64(79): 20312-3, 1999

Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014. Pharmacoepidemiology and Drug Safety 25(6): 713-718, 2016

High Prescription Drug Prices and the Influence of the Food and Drug Administration: In Response. Mayo Clinic Proceedings 79(4): 569-570, 2004

Planning In The Food And Drug Administration For Regulation Of Prescription Drug Advertising. Current Therapeutic Research, Clinical and Experimental 7: 332-336, 1965

High prescription drug prices and the influence of the Food and Drug Administration. Mayo Clinic Proceedings 79(4): 569; Discussion 569-70, 2004

How the US Food and Drug Administration can solve the prescription drug shortage problem. American Journal of Public Health 103(5): E10-E14, 2013

The Food and Drug Administration's regulation of prescription drug manufacturer speech: a First Amendment analysis. Food and Drug Law Journal 58(3): 365-437, 2003

Are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin. Pharmacoepidemiology and Drug Safety 22(12): 1258-1262, 2013

Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule. Federal Register 46(1): 28-30, 1980

Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule. Federal Register 45(179 Pt 2): 60754-60784, 1980